AJP - Renal Physiology, Vol 252, Issue 2 331-F337, Copyright © 1987 by American Physiological Society

ARTICLES

Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney

W. Lieberthal, M. L. Vasilevsky, C. R. Valeri and N. G. Levinsky

Interactions between antidiuretic hormone (ADH) and renal prostaglandins in the regulation of sodium reabsorption and urinary concentrating ability were studied in isolated erythrocyte-perfused rat kidneys (IEPK). In this model, hemodynamic characteristics are comparable to those found in vivo, and tubular morphology is preserved throughout the period of perfusion. [Deamino]-D-arginine vasopressin (dDAVP) markedly reduced fractional sodium excretion (FE Na) in the IEPK from 3.5 +/- 0.6 to 0.45 +/- 0.14%. After indomethacin, FE Na fell still further to 0.08 +/- 0.02%. In the absence of dDAVP indomethacin had no effect on sodium excretion; FE Na was 2.4 +/- 0.6% in control and 2.0 +/- 0.4% in indomethacin-treated groups. dDAVP increased urine osmolality in the IEPK to 741 +/- 26 mosmol/kg. When prostaglandin synthesis was blocked with indomethacin, urinary osmolality increased further to 1,180 +/- 94 mosmol/kg. In isolated kidneys perfused without erythrocytes (IPK), dDAVP decreased FENa from 14.5 +/- 1.8% to 9.6 +/- 1.2%; addition of indomethacin had no further effect. dDAVP increased urine osmolality only modestly to 350 +/- 12 mosmol/kg in the IPK and indomethacin did not increase concentrating ability further (342 +/- 7 mosmol/kg). Thus the IEPK (unlike the IPK) can excrete a markedly hypertonic urine in response to ADH. ADH also enhances tubular reabsorption of sodium in the IEPK. Prostaglandins inhibit both these actions of ADH but do not directly affect sodium excretion in the absence of the hormone.

This article has been cited by other articles:

				J. Perucca, N. Bouby, P. Valeix, and L. Bankir Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R700 - R705. [Abstract] [Full Text] [PDF]

				L. M. Russo, M. McKee, and D. Brown Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney Am J Physiol Renal Physiol, July 1, 2006; 291(1): F246 - F253. [Abstract] [Full Text] [PDF]

				J. A. Schafer Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct Am J Physiol Renal Physiol, August 1, 2002; 283(2): F221 - F235. [Abstract] [Full Text] [PDF]

				C. Nicco, M. Wittner, A. DiStefano, S. Jounier, L. Bankir, and N. Bouby Chronic Exposure to Vasopressin Upregulates ENaC and Sodium Transport in the Rat Renal Collecting Duct and Lung Hypertension, November 1, 2001; 38(5): 1143 - 1149. [Abstract] [Full Text] [PDF]

				G. J. Cowin, S. Crozier, Z. H. Endre, I. A. Leditschke, and I. M. Brereton Cortical and medullary betaine-GPC modulated by osmolality independently of oxygen in the intact kidney Am J Physiol Renal Physiol, September 1, 1999; 277(3): F338 - F346. [Abstract] [Full Text] [PDF]

				M. Heringlake, K. Wagner, J. Schumacher, and H. Pagel Urinary excretion of urodilatin is increased during pressure natriuresis in the isolated perfused rat kidney Am J Physiol Renal Physiol, September 1, 1999; 277(3): F347 - F351. [Abstract] [Full Text] [PDF]

				T. Wittwer, T. Wahlers, J. F. Cornelius, S. Elki, and A. Haverich Celsior solution for improvement of currently used clinical standards of lung preservation in an ex vivo rat model Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 667 - 671. [Abstract] [Full Text] [PDF]

				K. Higaki, T. Yukawa, M. Takeuchi, K. Nezasa, and M. Nakano Stereoselective Uptake of an Organic Anion Across the Renal Basolateral Membrane in Isolated Perfused Rat Kidney Drug Metab. Dispos., February 1, 1998; 26(2): 138 - 145. [Abstract] [Full Text]

				T. Nakamura, T. Sakamaki, T. Kurashina, K. Sato, Z. Ono, and K. Murata Effect of Renal Perfusion Pressure on Renal Interstitial Hydrostatic Pressure and Sodium Excretion : Role of Vasopressin V1 and V2 Receptors Hypertension, April 1, 1995; 25(4): 866 - 871. [Abstract] [Full Text]